Fig. 3.
Levels of TACE and TACE substrates in CAD patients and controls. Plasma levels of LDLR, TRANCE, CSF-1, LAG-3, JAM-A, and ACE2 were significantly higher in CAD compared to controls after adjusting for age, gender, BMI and cholesterol levels.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.